Multiple sclerosis: open trials in Norway

• NCT07299019

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC

  Vestre Viken HF, Drammen

  Registry updated 2026-10-27

• 2025-522140-40-00

  TARGET-EBV in MS: Targeting Epstein Barr Virus with Tenofovir Alafenamide Fumarate in multiple sclerosis

  Trial Treatment · Phase 2 · Oslo University Hospital HF

  Haukeland Universitetssykehus, Bergen · Vestre Viken HF, Drammen · Akershus University Hospital, Lørenskog · Oslo University Hospital HF, Oslo · Stavanger Univ. Hosp.-Rogaland Hosp., Stavanger

  Registry updated 2026-10-16

• 2025-521546-23-00

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Helse Moere Og Romsdal HF, Aalesund · Helse Bergen HF, Bergen · Oslo Universitetssykehus HF, Oslo

  Registry updated 2026-07-30

• NCT07444047

  MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis

  Research · Oslo University Hospital

  Oslo University Hospital, Oslo

  Registry updated 2026-06-01

• NCT06663111

  Rituximab and Ocrelizumab in Serum With Multiple Sclerosis

  Research · Haukeland University Hospital

  Haukeland University Hospital, Deparment of medical biochemistry and pharmacology, Bergen

  Registry updated 2024-10-29

• NCT05740722

  Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis

  Trial Treatment · Phase 2 · Haukeland University Hospital

  Haukeland University Hospital, Bergen

  Registry updated 2024-01-11

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error